Terug
74
Dagbereik
€ 80,70
€ 83,75
52-Weeksbereik
€ 45,91
€ 122,20
Volume
771.417
50D / 200D Gem.
€ 99,01
/
€ 96,18
Vorige Slotkoers
€ 84,65
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -28,7 | 0,3 |
| P/B | 40,6 | 2,9 |
| ROE % | -129,5 | 3,7 |
| Net Margin % | -103,6 | 3,8 |
| Rev Growth 5Y % | 178,5 | 10,0 |
| D/E | 1,8 | 0,2 |
Koersdoel Analisten
Hold
€ 140,18
+69.7%
Low: € 125,00
High: € 157,00
Forward WPA
-€ 3,08
Omzet Sch.
290 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 12,09
€ 8,29 – € 14,94
|
1,9 B | 3 |
| FY2029 |
€ 7,49
€ 5,13 – € 9,25
|
1,4 B | 3 |
| FY2028 |
€ 3,08
€ 0,10 – € 5,89
|
900 M | 9 |
Belangrijkste Punten
Revenue grew 178,51% annually over 5 years — strong growth
Negative free cash flow of -116,63M
Revenue growth is decelerating — 1Y growth trails 5Y average by 132,68%
Capital efficient — spends only 0,50% of revenue on capex
Groei
Revenue Growth (5Y)
178,51%
Revenue (1Y)45,83%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-129,46%
ROIC-37,35%
Net Margin-103,57%
Op. Margin-101,19%
Veiligheid
Debt / Equity
1,77
Current Ratio4,41
Interest Coverage-9,33
Waardering
P/E Ratio
-28,69
P/B Ratio40,55
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 45,83% | Revenue Growth (3Y) | 56,55% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 178,51% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 189,76M | Net Income (TTM) | -196,54M |
| ROE | -129,46% | ROA | -40,84% |
| Gross Margin | 89,73% | Operating Margin | -101,19% |
| Net Margin | -103,57% | Free Cash Flow (TTM) | -116,63M |
| ROIC | -37,35% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1,77 | Current Ratio | 4,41 |
| Interest Coverage | -9,33 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -28,69 | P/B Ratio | 40,55 |
| P/S Ratio | 29,72 | PEG Ratio | 1,25 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 5,64B | Enterprise Value | 5,83B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 189,76M | 130,13M | 77,43M | 23,64M | 3,15M |
| Net Income | -196,54M | -260,60M | -184,68M | -181,12M | -69,61M |
| EPS (Diluted) | -3,11 | -4,34 | -3,20 | -3,51 | -1,37 |
| Gross Profit | 170,27M | 116,76M | 68,13M | 21,51M | 2,56M |
| Operating Income | -192,02M | -265,50M | -184,36M | -179,16M | -170,06M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 481,19M | 392,27M | 332,75M | 382,48M | 329,52M |
| Total Liabilities | 342,13M | 227,72M | 162,99M | 118,22M | 45,37M |
| Shareholders' Equity | 139,07M | 164,55M | 169,76M | 264,26M | 284,15M |
| Total Debt | 246,47M | 3,94M | 1,26M | 1,94M | 2,55M |
| Cash & Equivalents | 54,30M | 89,14M | 60,08M | 127,68M | 59,25M |
| Current Assets | 466,92M | 374,20M | 308,27M | 354,24M | 308,39M |
| Current Liabilities | 105,94M | 115,52M | 55,20M | 39,81M | 43,43M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#9 of 146
Recente Activiteit
Ingestapt
Full Throttle
Mar 24, 2026